Clinical trialNCT01051921CompletedPhase 2Interventional

Study of CTS-1027 in Combination With Pegylated Interferon and Ribavirin in Hepatitis C Virus (HCV) Null-Responders

SponsorConatus Pharmaceuticals Inc.Enrollment67Hepatitis C

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine if the combination treatment of CTS-1027, pegylated interferon and ribavirin can improve the response rates in HCV patients who did not previously respond to pegylated interferon and ribavirin therapy.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Erin Castelloe, MD
Conatus Pharmaceuticals Inc.
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Puerto Rico

Fundacion de Investigacion de Diego
Santurce, Puerto Rico

United States

Scripps Clinic
La Jolla, California, United States
Va Medical Center, San Diego
San Diego, California, United States
University of Colorado Health Science Center
Denver, Colorado, United States
South Denver Gastroenterology
Englewood, Colorado, United States
Digestive Healthcare of Georgia
Atlanta, Georgia, United States
Tulane University Health Sciences Center
New Orleans, Louisiana, United States
Henry Ford Medical Center-Columbus
Novi, Michigan, United States
Mn Clinical Research Center
Plymouth, Minnesota, United States
St. Louis University
St Louis, Missouri, United States
Consultants of Clinical Research, Ohio Gi and Liver Institute
Cincinnati, Ohio, United States
Advanced Liver Therapies - Baylor College of Medicine
Houston, Texas, United States
Va Medical Center, Houston
Houston, Texas, United States
University of Utah Health Science Center
Salt Lake City, Utah, United States
Liver Institute of Virginia
Newport News, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

CTS-1027Pegylated interferonRibavirin →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Jan 2010
Primary completion: 30 Nov 2011
Completion: 31 Dec 2011
Last update posted: 16 Apr 2012
Registered enrollment: 67
Registry id: NCT01051921

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.